Natixis’s Madrigal Pharmaceuticals MDGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-857
| Closed | -$198K | – | 1111 |
|
|
2023
Q4 | $198K | Sell |
857
-45
| -5% | -$10.4K | ﹤0.01% | 696 |
|
|
2023
Q3 | $132K | Buy |
+902
| New | +$132K | ﹤0.01% | 743 |
|
|
2023
Q2 | – | Sell |
-1,109
| Closed | -$269K | – | 1076 |
|
|
2023
Q1 | $269K | Buy |
+1,109
| New | +$269K | ﹤0.01% | 699 |
|
|
2021
Q2 | – | Sell |
-22,000
| Closed | -$2.57M | – | 915 |
|
|
2021
Q1 | $2.57M | Sell |
22,000
-31,722
| -59% | -$3.71M | 0.01% | 638 |
|
|
2020
Q4 | $5.97M | Sell |
53,722
-25,412
| -32% | -$2.82M | 0.02% | 484 |
|
|
2020
Q3 | $9.4M | Buy |
+79,134
| New | +$9.4M | 0.07% | 196 |
|